.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Novartis
Covington
Federal Trade Commission
Harvard Business School
Fish and Richardson
Boehringer Ingelheim
Farmers Insurance
Cipla

Generated: June 27, 2017

DrugPatentWatch Database Preview

Hyaluronidase - Generic Drug Details

« Back to Dashboard

What are the generic sources for hyaluronidase and what is the scope of hyaluronidase patent protection?

Hyaluronidase
is the generic ingredient in five branded drugs marketed by Akorn Inc, Bausch And Lomb, Baxter Hlthcare, Amphastar Pharm, and Halozyme Therap, and is included in five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for hyaluronidase. Four suppliers are listed for this compound.

Summary for Generic Name: hyaluronidase

Tradenames:5
Patents:2
Applicants:5
NDAs:5
Drug Master File Entries: see list6
Suppliers / Packagers: see list4
Clinical Trials: see list60
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hyaluronidase at DailyMed

Pharmacology for Ingredient: hyaluronidase

Ingredient-typeGlycoside Hydrolases
Drug ClassEndoglycosidase
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
VITRASE
hyaluronidase
INJECTABLE;INJECTION021640-002Dec 2, 2004RXYesYes► Subscribe► Subscribe
Baxter Hlthcare
WYDASE
hyaluronidase
INJECTABLE;INJECTION006343-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Halozyme Therap
HYLENEX RECOMBINANT
hyaluronidase recombinant human
INJECTABLE;INJECTION021859-001Dec 2, 2005RXYesYes7,767,429► SubscribeYY ► Subscribe
Akorn Inc
HYDASE
hyaluronidase
INJECTABLE;INJECTION021716-001Oct 25, 2005DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
WYDASE
hyaluronidase
INJECTABLE;INJECTION006343-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Medtronic
AstraZeneca
Healthtrust
Daiichi Sankyo
Farmers Insurance
Merck
Fish and Richardson
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot